Order Article Reprints

Ramos GS, Vallejos VMR, Borges GSM, Almeida RM, Alves IM, Aguiar MMG, Fernandes C, Guimarães PPG, Fujiwara RT, Loiseau PM, et al. Formulation of Amphotericin B in PEGylated Liposomes for Improved Treatment of Cutaneous Leishmaniasis by Parenteral and Oral Routes. Pharmaceutics. 2022; 14(5):989. https://doi.org/10.3390/pharmaceutics14050989

Ramos, Guilherme S., Virgínia M. R. Vallejos, Gabriel S. M. Borges, Raquel M. Almeida, Izabela M. Alves, Marta M. G. Aguiar, Christian Fernandes, Pedro P. G. Guimarães, Ricardo T. Fujiwara, Philippe M. Loiseau, and et al. 2022. "Formulation of Amphotericin B in PEGylated Liposomes for Improved Treatment of Cutaneous Leishmaniasis by Parenteral and Oral Routes" Pharmaceutics 14, no. 5: 989. https://doi.org/10.3390/pharmaceutics14050989

Ramos, G. S., Vallejos, V. M. R., Borges, G. S. M., Almeida, R. M., Alves, I. M., Aguiar, M. M. G., Fernandes, C., Guimarães, P. P. G., Fujiwara, R. T., Loiseau, P. M., Ferreira, L. A. M., & Frézard, F. (2022). Formulation of Amphotericin B in PEGylated Liposomes for Improved Treatment of Cutaneous Leishmaniasis by Parenteral and Oral Routes. Pharmaceutics, 14(5), 989. https://doi.org/10.3390/pharmaceutics14050989